{"title":"设计新药临床试验","authors":"Jennifer E. Miller, A. Caplan, A. Blasimme","doi":"10.14524/CR-15-0045","DOIUrl":null,"url":null,"abstract":"Much has been written about the ethics of healthcare innovation and the role of pharmaceutical companies in innovation. Rightly or wrongly, the scholarship and media coverage has been disparaging. Many commentators fear that the biopharmaceutical sector no longer serves patients’ interests; they","PeriodicalId":90809,"journal":{"name":"Clinical researcher (Alexandria, Va.)","volume":"13 1","pages":"34-39"},"PeriodicalIF":0.0000,"publicationDate":"2016-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Designing Clinical Trials for New Drugs\",\"authors\":\"Jennifer E. Miller, A. Caplan, A. Blasimme\",\"doi\":\"10.14524/CR-15-0045\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Much has been written about the ethics of healthcare innovation and the role of pharmaceutical companies in innovation. Rightly or wrongly, the scholarship and media coverage has been disparaging. Many commentators fear that the biopharmaceutical sector no longer serves patients’ interests; they\",\"PeriodicalId\":90809,\"journal\":{\"name\":\"Clinical researcher (Alexandria, Va.)\",\"volume\":\"13 1\",\"pages\":\"34-39\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical researcher (Alexandria, Va.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14524/CR-15-0045\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical researcher (Alexandria, Va.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14524/CR-15-0045","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Much has been written about the ethics of healthcare innovation and the role of pharmaceutical companies in innovation. Rightly or wrongly, the scholarship and media coverage has been disparaging. Many commentators fear that the biopharmaceutical sector no longer serves patients’ interests; they
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
